Compliance

5MM: Job Openings Jump; Justifying EpiPen Costs

By Rick Bell

Sep. 15, 2016

In this week’s edition of 5 Minutes of Management, Workforce editors Frank Kalman and Rick Bell talk about the record number of job openings in the U.S. and tackle the finger pointing between an industry association, insurance firms and pharmacy benefits managers regarding the soaring cost of making pharmaceuticals such as the EpiPen. Also, why is the figure 20 million so significant?

 

 

Rick Bell is Workforce’s editorial director. For comments or questions email editors@workforce.com.

Schedule, engage, and pay your staff in one system with Workforce.com.

Recommended

Join over 52,000 of your HR peers

Don't miss out on the latest tactics and insights at the forefront of HR.